1. Kutschera, M.; Engst, W.; Blaut, M.; Braune, A. Isolation of catechin-converting human intestinal bacteria. J. Appl. Microbiol. 2011, 111(1), 165–175. DOI: 10.1111/j.1365-2672.2011.05025.x
2. Saura-Calixto, F.; Pérez-Jiménez, J.; Touriño, S.; Serrano, J.; Fuguet, E.; Torres, J. L.; Goñi, I. Proanthocyanidin metabolites associated with dietary fibre from in vitro colonic fermentation and proanthocyanidin metabolites in human plasma. Mol. Nutr. Food Res. 2010, 54(7), 939–946. DOI: 10.1002/mnfr.200900276
3. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81(1 Suppl), 230S–242S. DOI: 10.1093/ajcn/81.1.230S
4. Mena, P.; Bresciani, L.; Brindani, N.; Ludwig, I. A.; Pereira-Caro, G.; Angelino, D.; Llorach, R.; Calani, L.; Brighenti, F.; Clifford, M. N.; Gill, C. I. R.; Crozier, A.; Curti, C.; Del Rio, D. Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity. Nat. Prod. Rep. 2019, 36(5), 714–752. DOI: 10.1039/C8NP00062J
5. Lee, C. C.; Kim, J. H.; Kim, J. S.; Oh, Y. S.; Han, S. M.; Park, J. H. Y.; Lee, K. W.; Lee, C. Y. 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone, a major microbial metabolite of proanthocyanidin, attenuates THP-1 monocyte-endothelial adhesion. Int. J. Mol. Sci. 2017, 18(7), Art. No: 1363. DOI: 10.3390/ijms18071363
6. Theodoratou, E.; Kyle, J.; Farrington, S. M.; Barnetson, R.; Tenesa, A.; Cetnarskyj, R.; Dunlop, M.; Porteous, M.; Campbell, H. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16(4), 684–693. DOI: 10.1158/1055-9965.EPI-06-0785
7. Yanez-Gascon, M. J.; Larrosa, M.; Simona, T.; Espin, J. C.; Tomas-Barberan, F.; Piero, D.; Selma, M. V.; Gonzalez-Sarrias, A.; Azorin-Ortuno, M. Anti-inflammatory activity of pomegranate extract and urolithin-A in experimental rat colitis and the influence of colonic inflammation on phenolic biotransformation. J. Nutr. Biochem. 2010, 21(8), 717–725. DOI: 10.1016/j.jnutbio.2009.04.012
8. Rechner, A. R.; Kroner, C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb. Res. 2005, 116(4), 327–334. DOI: 10.1016/j.thromres.2005.01.002
9. Kim, T.D.A.; Kim, R.A.; Suh, G.Y.; Sim, H.J. DHPV Novel method for synthesizing DHPV. KR Patent KR102003033B1 2019. https://worldwide.espacenet.com/patent/search/family/067439865/publication/KR102003033B1?q=pn=KR102003033
10. Hur, J.; Kim, A.-R.; Kim, S. H.; Lim, C.; Kim, T.; Kim, T.-A.; Sim, J.; Suh, Y.-G. Concise synthesis of catechin metabolites 5-(3′,4′-dihydroxyphenyl)-γ-valerolactones (DHPV) in optically pure form and their stereochemical effects on skin wrinkle-reducing activities. Molecules 2020, 25(8), Art. No: 1970. DOI: 10.3390/molecules25081970
11. Lambert, J. D.; Rice, J. E.; Hong, J.; Hou, Z.; Yang, C. S. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorg. Med. Chem. Lett. 2005, 15(4), 873–876. DOI: 10.1016/j.bmcl.2004.12.070
12. Chang, X.; Peng, W.; Yao, Y.-F.; Koek, J. Concise synthesis of ring-fission metabolites of epicatechin: 5-(3,4-dihydroxybenzyl)dihydrofuran-2(3H)-one M6. Synth. Commun. 2010, 40(22), 3346–3352. DOI: 10.1080/00397910903419845
13. Nishirawa, T.; Kubo, H.; Saito, M.; Yoshiue, S.; Tamura, Z. Presence of (±)-δ-(3,4-dihydroxyphenyl)-γ-valerolactone in human urine. Chem. Pharm. Bull. 1974, 22(11), 2573–2577. DOI: 10.1248/cpb.22.2573